Acute Myocarditis Registry With Prognostic, Histologic, Immunologic, Biological, Imaging and Clinical Assessment

ConditionMyocarditis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age15+
SponsorAssistance Publique - Hôpitaux de Paris

About this trial

The AMPHIBIA study is an observational ambispective and prospective cohort that aim to describe the histologic, immunologic, biological, imaging, genetic and clinical characteristics of the patients hospitalized for an acute myocarditis and to evaluate their association with prognosis.

Eligibility criteria

Qualifiers

Acute myocarditis confirmed by cardiac magnetic resonance according to Lake Louise modified criteria or by endomyocardial biopsy according to histologic, immunologic and immunohistochemic criteria.

affiliation to the French Health Care System "Sécurité sociale"

Disqualifiers

Severe valvulopathy

Complex congenital cardiopathy

Previous heart transplant

Known significative coronary disease

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

1,400 Participants
are grouped into 1 trial group